GSTM1 and chronic kidney disease: The model is used to predict the Hb outcomes with Q2W (biweekly) and TIW (thrice weekly) dosing of epoetin alfa compared to the calibrated QW (weekly) dosing in anemic CKD ND subjects (Pergola et al., 2009).